Literature DB >> 22067002

Predictors for the development of severe tricuspid regurgitation with anatomically normal valve in patients with atrial fibrillation.

Mohammad Q Najib1, Karyne L Vinales, Satya S Vittala, Suresh Challa, Howard R Lee, Hari P Chaliki.   

Abstract

BACKGROUND AND AIMS: Atrial fibrillation (AF) may be a risk factor for severe functional tricuspid valve regurgitation (FTR). We aimed to determine the predictors of severe FTR in patients with AF. METHODS AND
RESULTS: From our echocardiographic laboratory database, we searched for and reviewed the medical records of consecutive patients with severe FTR and AF seen at Mayo Clinic in Arizona from 2002 through 2009. Our search identified 42 patients who met all inclusion criteria. These patients (cases) with severe FTR and AF were compared with 38 patients (controls) with AF who had no greater than mild tricuspid regurgitation. Case patients with severe FTR were older than controls (mean, 81 years vs. 76 years; P < 0.001) and more frequently had chronic AF (69% vs 26%; P < 0.001). Mean right atrial volume (86 mL/m(2) vs 46 mL/m(2) ; P < 0.001), right ventricular volume (42 mL ± 33 mL vs 22 mL ±8 mL; P < 0.001) and tricuspid annular diameter (3.6 cm vs 3.0 cm; P < 0.001) were larger in cases than in controls. Patients with severe FTR also had a higher prevalence of right-sided heart failure (69% vs 16%; P < 0.001). After adjusting for age and gender, right atrial and right ventricular volumes were independent predictors for the development of severe FTR in patients with AF (odds ratio, 1.7 [95% CI, 1.3-2.8] for every 10 mL/m(2) increase in right atrial volume; P = 0.0002 and odds ratio, 3.1 [95% CI, 1.5-8.9] for every 10 mL increase in right ventricular volume; P = 0.0002).
CONCLUSIONS: Severe FTR occurs in older patients with chronic AF as a result of marked right atrial and right ventricular dilatation; and enlargement of the tricuspid annulus in the absence of pulmonary hypertension. More importantly, severe FTR leads to increased prevalence of right-sided heart failure underscoring the nonbenign nature of chronic AF.
© 2011, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22067002     DOI: 10.1111/j.1540-8175.2011.01565.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  18 in total

Review 1.  Tricuspid regurgitation: pathophysiology and management.

Authors:  Rashmi Thapa; Buddhadeb Dawn; Jayant Nath
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 2.  Tricuspid valve incompetence following implantation of ventricular leads.

Authors:  Giselle A Baquero; Jerry Luck; Gerald V Naccarelli; Mario D Gonzalez; Javier E Banchs
Journal:  Curr Heart Fail Rep       Date:  2015-04

Review 3.  Evidence-based surgical management of acquired tricuspid valve disease.

Authors:  Sung Ho Shinn; Hartzell V Schaff
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

Review 4.  Contemporary review in the multi-modality imaging evaluation and management of tricuspid regurgitation.

Authors:  Tom Kai Ming Wang; Shinya Unai; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

5.  Predictors of severe tricuspid regurgitation in patients with permanent pacemaker or automatic implantable cardioverter-defibrillator leads.

Authors:  Mohammad Q Najib; Satya S Vittala; Suresh Challa; Amol Raizada; Fernando J Tondato; Howard R Lee; Hari P Chaliki
Journal:  Tex Heart Inst J       Date:  2013

6.  Transcatheter Treatment of Functional Tricuspid Regurgitation Using the Trialign Device.

Authors:  Christian Besler; Christopher U Meduri; Philipp Lurz
Journal:  Interv Cardiol       Date:  2018-01

7.  Clinical performance and exercise hemodynamics in patients with severe secondary tricuspid regurgitation and chronic atrial fibrillation.

Authors:  Jesper K Jensen; Tor S Clemmensen; Christian A Frederiksen; Joachim Schofer; Mads J Andersen; Steen H Poulsen
Journal:  BMC Cardiovasc Disord       Date:  2021-06-04       Impact factor: 2.298

8.  Pacemaker lead-associated tricuspid regurgitation in patients with or without pre-existing right ventricular dilatation.

Authors:  Martin Riesenhuber; Andreas Spannbauer; Marianne Gwechenberger; Thomas Pezawas; Christoph Schukro; Günter Stix; Matthias Schneider; Georg Goliasch; Anahit Anvari; Thomas Wrba; Cesar Khazen; Martin Andreas; Günther Laufer; Christian Hengstenberg; Mariann Gyongyosi
Journal:  Clin Res Cardiol       Date:  2021-02-10       Impact factor: 5.460

9.  Impact of Surgical Ablation of Atrial Fibrillation on the Progression of Tricuspid Regurgitation and Right-Sided Heart Remodeling After Mitral-Valve Surgery: A Propensity-Score Matching Analysis.

Authors:  Jiangang Wang; Jie Han; Yan Li; Qing Ye; Fei Meng; Tiange Luo; Baiyu Tian; Haibo Zhang; Yixin Jia; Wen Zeng; Chunlei Xu; Wei Han; Yuqing Jiao; Xu Meng
Journal:  J Am Heart Assoc       Date:  2016-12-05       Impact factor: 5.501

10.  Clinical and Echocardiographic Factors Affecting Tricuspid Regurgitation Severity in the Patients with Lone Atrial Fibrillation.

Authors:  Jae-Hyung Park; Sung-Hee Shin; Man-Jong Lee; Myung-Dong Lee; Hyun-Ik Shim; Jaewoong Yoon; Sehwan Oh; Dae-Hyeok Kim; Sang-Don Park; Sung-Woo Kwon; Seong-Ill Woo; Keum-Soo Park; Jun Kwan
Journal:  J Cardiovasc Ultrasound       Date:  2015-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.